Raising funds for growth investments through a third-party allotment and stock acquisition rights
First written in FY2021-Q1. 8 of 9 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2025-H1.
The whole theme swung hardest in 2020: 1 of 10 companies on the "Worse" side.
6 other companies' latest entry also says "Advanced".
- FY2025-H1AdvancedAnnual report
「Proceeds from the issuance of shares through the exercise of stock acquisition rights: ¥19.494 million」
The exercise of stock acquisition rights originating from the third-party allotment progressed during the current interim consolidated accounting period, and ¥19.494 million in proceeds from the issuance of shares was recognised. The total number of shares issued increased by 119,600 as a result of the exercise. - FY2025-Q1AdvancedAnnual report
「1 March 2024–31 May 2024 (Note) 1,200 10,769,660 97 792,639 97 733,584 (Note) Increase resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 1,200 shares during the current first quarter, increasing share capital and capital surplus by ¥97 thousand each. The financing method originating from the third-party allotment continues to be exercised. - FY2024AdvancedAnnual report
「Proceeds from the issuance of shares through the exercise of stock acquisition rights: ¥13.040 million」
The stock acquisition rights issued through the third-party allotment continued to be exercised, and ¥13.040 million in proceeds from the issuance of shares was recognised during the consolidated fiscal year. - FY2024-Q3AdvancedAnnual report
「1 September 2023–30 November 2023 (Note) 6,400 10,768,460 521 792,541 521 733,486 (Note) Increase resulting from the exercise of stock acquisition rights.」
The stock acquisition rights issued through the third-party allotment continued to be exercised, resulting in the issuance of 6,400 shares during the quarter and increases of ¥521 thousand each in share capital and capital surplus. - FY2024-Q2AdvancedAnnual report
「Proceeds from the issuance of shares through the exercise of stock acquisition rights: ¥11.996 million」
The exercise of stock acquisition rights issued through the third-party allotment resulted in ¥11.996 million in proceeds from the issuance of shares during the cumulative second quarter of the current fiscal year. - FY2023-Q2AdvancedAnnual report
「Proceeds from the issuance of shares through the exercise of stock acquisition rights: ¥5.020 million」
The stock acquisition rights issued through the third-party allotment were exercised during the cumulative second quarter of the current fiscal year, and ¥5.020 million in proceeds from the issuance of shares was recognised. The financing method has progressed to an additional exercise stage. - FY2023-Q1AdvancedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
The stock acquisition rights issued through the third-party allotment were exercised during the current first quarter, increasing the total number of shares issued by 30,400. This indicates that the financing method proceeded to the exercise stage after implementation. - FY2021-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 14 July 2020, the Company resolved to issue 325,000 common shares of 株式会社ロゼッタ and its 14th Stock Acquisition Rights through a third-party allotment, and the payment procedures were completed on 30 July 2020.」
For the planned third-party allotment, the issuance and payment procedures for 325,000 common shares and the 14th Stock Acquisition Rights were completed on 30 July 2020. - FY2021-Q1First statedAnnual report
「Method: third-party allotment; planned allottee: CVI Investments, Inc.; use of funds: ① M&A to expand market share and strengthen development in document translation」
The Company resolved to conduct a third-party allotment of 325,000 common shares scheduled to be paid in on 30 July 2020 and to issue 12,188 units of the 14th Stock Acquisition Rights. The funds were to be used for M&A and development enhancement in document translation, T-4PO and AI RPA. The exercise period for the Stock Acquisition Rights was set from 31 July 2020 to 30 July 2024.